Tumour necrosis factor-α stimulates human neutrophils to release preformed activin A

Immunology and Cell Biology

Volumn 89, Issue 8, 2011, Pages 889-896

  Chen, Yi ^a,b   Wu, Hui ^a   Winnall, Wendy R ^a   Loveland, Kate L ^b   Makanji, Yogeshwar ^a   Phillips, David J ^a   Smith, Julian A ^b   Hedger, Mark P ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

cytokine; immunoassay; inflammation; leukocytes; lipopolysaccharide

Indexed keywords

ACTIVIN A; DIMER; FICOLL; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOMER; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MONONUCLEAR CELL; NEUTROPHIL;

ACTIVINS; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMIDAZOLES; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; NEUTROPHILS; PYRIDINES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80855132927     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.12     Document Type: Article

References (50)

1. Lin SJ, Lerch TF, Cook RW, Jardetzky TS, Woodruff TK. The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding. Reproduction 2006; 132: 179-190. (Pubitemid 44269702)
2. Phillips DJ, de Kretser DM, Hedger MP. Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev 2009; 20: 153-164.
3. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA 2007; 104: 16239-16244. (Pubitemid 350099391)
4. Jones KL, de Kretser DM, Clarke IJ, Scheerlinck JPY, Phillips DJ. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. J Endocrinol 2004; 182: 69-80. (Pubitemid 39076903)
5. Wilms H, Schwark T, Brandenburg LO, Sievers J, Dengler R, Deuschl G et al. Regulation of activin A synthesis in microglial cells: pathophysiological implications for bacterial meningitis. J Neurosci Res 2010; 88: 16-23.
6. Robson NC, Phillips DJ, McAlpine T, Shin A, Svobodova S, Toy T et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 2008; 111: 2733-2743.
7. Wilson KM, Smith AI, Phillips DJ. Stimulatory effects of lipopolysaccharide on endothelial cell activin and follistatin. Mol Cell Endocrinol 2006; 253: 30-35. (Pubitemid 43946566)
8. Cho SH, Yao Z, Wang SW, Alban RF, Barbers RG, French SW et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 2003; 170: 4045-4052. (Pubitemid 36428166)
9. Hardy CL, Lemasurier JS, Olsson F, Dang T, Yao J, Yang M et al. IL-13 regulates secretion of the TGF-{beta} superfamily cytokine activin A in allergic airway inflammation. Am J Respir Cell Mol Biol 2010; 42: 667-675.
10. Liu L, Kelly EA, Jarjour NN. Activin A is synthesized by human eosinophils and is selectively induced by IL-3 in combination with TNF-alpha. Am J Respir Crit Care Med 2010; 181: A2799.
11. Ogawa K, Funaba M, Tsujimoto M. A dual role of activin A in regulating immunoglobulin production of B cells. J Leukoc Biol 2008; 83: 1451-1458. (Pubitemid 351960326)
12. Tannetta DS, Muttukrishna S, Groome NP, Redman CW, Sargent IL. Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia. J Clin Endocrinol Metab 2003; 88: 5995-6001. (Pubitemid 38033084)
13. Andonegui G, Goyert SM, Kubes P. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels. J Immunol 2002; 169: 2111-2119. (Pubitemid 34857677)
14. Bozza PT, Castro-Faria-Neto HC, Silva AR, Larangeira AP, Silva PM, Martins MA et al. Lipopolysaccharide-induced pleural neutrophil accumulation depends on marrow neutrophils and platelet-activating factor. Eur J Pharmacol 1994; 270: 143-149.
15. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6: 173-182. (Pubitemid 43290987)
16. Takahashi S, Uchimaru K, Harigaya K, Asano S, Yamashita T. Tumor necrosis factor and interleukin-1 induce activin A gene expression in a human bone marrow stromal cell line. Biochem Biophys Res Commun 1992; 188: 310-317.
17. Onnheim K, Bylund J, Boulay F, Dahlgren C, Forsman H. Tumour necrosis factor (TNF)-alpha primes murine neutrophils when triggered via formyl peptide receptor-related sequence 2, the murine orthologue of human formyl peptide receptor-like 1, through a process involving the type I TNF receptor and subcellular granule mobilization. Immunology 2008; 125: 591-600.
18. Frasch SC, Nick JA, Fadok VA, Bratton DL, Worthen GS, Henson PM. p38 mitogen-activated protein kinase-dependent and-independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem 1998; 273: 8389-8397. (Pubitemid 28168900)
19. Funaba M, Ikeda T, Ogawa K, Abe M. Calcium-regulated expression of activin A in RBL-2H3 mast cells. Cell Signal 2003; 15: 605-613. (Pubitemid 36385166)
20. Myskiw C, Arsenio J, van Bruggen R, Deschambault Y, Cao J. Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol 2009; 83: 6757-6768.
21. Robertson DM, Foulds LM, Prisk M, Hedger MP. Inhibin/activin beta-subunit monomer: isolation and characterization. Endocrinology 1992; 130: 1680-1687.
22. Husken-Hindi P, Tsuchida K, Park M, Corrigan AZ, Vaughan JM, Vale WW et al. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity. J Biol Chem 1994; 269: 19380-19384. (Pubitemid 24233460)
23. Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 2002; 100: 1860-1868. (Pubitemid 34925167)
24. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002; 168: 4701-4710. (Pubitemid 34441378)
25. Shao L, Frigon Jr NL, Sehy DW, Yu AL, Lofgren J, Schwall R et al. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol 1992; 20: 1235-1242.
26. Hubner G, Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996; 228: 106-113. (Pubitemid 26349719)
27. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346: 274-276.
28. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491-503.
29. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998; 42: 470-476. (Pubitemid 28186561)
30. Oishi K, Machida K. Some plasma component is essential for IL-6 secretion by neutrophils. Environ Health Prev Med 1997; 2: 89-92. (Pubitemid 27485580)
31. Zu YL, Qi J, Gilchrist A, Fernandez GA, Vazquez-Abad D, Kreutzer DL et al. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J Immunol 1998; 160: 1982-1989. (Pubitemid 28106489)
32. Sternberg D, Honigwachs-sha'anani J, Brosh N, Malik Z, Burstein Y, Zipori D. Restrictin-P/stromal activin A, kills its target cells via an apoptotic mechanism. Growth Factors 1995; 12: 277-287. (Pubitemid 26046273)
33. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillett NA. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 1994; 20: 854-862. (Pubitemid 24978376)
34. Maeshima A, Nojima Y, Kojima I. Activin A: an autocrine regulator of cell growth and differentiation in renal proximal tubular cells. Kidney Int 2002; 62: 446-454. (Pubitemid 34779755)
35. Wang B, Feng Y, Song X, Liu Q, Ning Y, Ou X et al. Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A-induced apoptosis in A549. Toxicology 2009; 258: 176-183.
36. Sugama S, Takenouchi T, Kitani H, Fujita M, Hashimoto M. Activin as an anti-inflammatory cytokine produced by microglia. J Neuroimmunol 2007; 192: 31-39. (Pubitemid 350213114)
37. Wang SY, Tai GX, Zhang PY, Mu DP, Zhang XJ, Liu ZH. Inhibitory effect of activin A on activation of lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Cyto-kine 2008; 42: 85-91.
38. Russell CE, Hedger MP, Brauman JN, de Kretser DM, Phillips DJ. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol 1999; 148: 129-136. (Pubitemid 29136906)
39. Hedger MP, Phillips DJ, de Kretser DM. Divergent cell-specific effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1beta or interleukin 6 in vitro. Cytokine 2000; 12: 595-602. (Pubitemid 30453487)
40. Cassatella MA, Locati M, Mantovani A. Never underestimate the power of a neutrophil. Immunity 2009; 31: 698-700.
41. Zhang X, Majlessi L, Deriaud E, Leclerc C, Lo-Man R. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 2009; 31: 761-771.
42. Vaughan JM, Rivier J, Corrigan AZ, McClintock R, Campen CA, Jolley D et al. Detection and purification of inhibin using antisera generated against synthetic peptide fragments. Methods Enzymol 1989; 168: 588-617. (Pubitemid 19136110)
43. Nauseef WM. Isolation of human neutrophils from venous blood. Methods Mol Biol 2007; 412: 15-20.
44. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor: NY, 1988.
45. Makanji Y, Harrison CA, Stanton PG, Krishna R, Robertson DM. Inhibin A and B in vitro bioactivities are modified by their degree of glycosylation and their affinities to betaglycan. Endocrinology 2007; 148: 2309-2316. (Pubitemid 46997083)
46. Barakat B, O'Connor AE, Gold E, de Kretser DM, Loveland KL. Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice. Reproduction 2008; 136: 345-359.
47. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148: 267-279. (Pubitemid 26051528)
48. Winnall WR, Okuma Y, Saito K, Muir JA, Hedger MP. Regulation of interleukin 1alpha, activin and inhibin by lipopolysaccharide in Sertoli cells from prepubertal rats. Mol Cell Endocrinol 2009; 307: 169-175.
49. Okuma Y, Saito K, O'Connor AE, Phillips DJ, de Kretser DM, Hedger MP. Reciprocal regulation of activin A and inhibin B by interleukin-1 (IL-1) and follicle-stimulating hormone (FSH) in rat Sertoli cells in vitro. J Endocrinol 2005; 185: 99-110. (Pubitemid 40585071)
50. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apop-tosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184: 39-51.